SEC Filing Summary for KESTRA MEDICAL TECHNOLOGIES, LTD.

Traci S. Umberger, General Counsel and Chief Administrative Officer of KESTRA MEDICAL TECHNOLOGIES, LTD., reported non-discretionary sales of common shares on July 30, July 31, and August 3, 2026. These sales, totaling 5,887 shares on July 30, 8,752 shares on July 31, and 7,590 shares on August 3, were conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units. The sales were executed at weighted average prices ranging from $22.24 to $23.17 on July 30, $22.17 to $22.92 on July 31, and $23.65 to $24.28 on August 3. Following these transactions, Umberger’s post-transaction share count decreased from 215,747 to 199,405 shares.